A gene variant called APOE4 dramatically increases the risk of late-onset Alzheimer’s disease, the most common form of dementia. Now, emerging research is revealing APOE4’s true role in the condition, and a new study pinpoints a possible way to treat it.

Historically, scientists studying Alzheimer’s disease have focused on two proteins that accumulate in patients’ brains: amyloid-beta and tau. However, there’s a “third thing that people didn’t pay attention to, until recently,” said study co-author Li-Huei Tsai, a neuroscientist at MIT. That third thing is the accumulation of droplets of fat, or lipids, in the brain, she told Live Science.

Latest Videos FromLive Science

You may like

What to read next

Myelin (orange) is a fatty material that coats the outgoing wires of many neurons, helping the cells send signals more efficiently.

(Image credit: koto_feja via Getty Images)

This article is for informational purposes only and is not meant to offer medical advice.

Akay, L. A., Bright, A., Dong, D., Smith, E. D., Hurt, R. C., Boix, C. A., Louderback, K., Medrano, J., Sun, D., Lin, H., King, O., Welch, G. M., Nawaid, H., Agbas, E., Jiang, A., Bubnys, A., Cheng, J., Blanchard, J. W., & Tsai, L. (2026). Genome-wide CRISPR screen reveals that Wnt signaling regulates lipid accumulation in APOE4 oligodendrocytes. Cell Stem Cell. https://doi.org/10.1016/j.stem.2026.09.012